Brussels - Delayed Quote EUR
BioSenic S.A. (BIOS.BR)
0.0016
+0.0001
+(6.67%)
As of 10:39:41 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
1,000
Operating Expense
7,040
7,040
2,319
878
16,017
Operating Income
-7,040
-7,040
-2,319
-878
-15,017
Net Non Operating Interest Income Expense
-2,716
-2,716
-286
-107
-723
Pretax Income
-29,028
-29,028
-3,049
-984
-15,754
Tax Provision
-7
-7
0
0
78
Net Income Common Stockholders
-28,778
-28,778
-2,041
-984
-11,940
Diluted NI Available to Com Stockholders
-28,778
-28,778
-2,041
-984
-11,940
Basic EPS
-0.21
--
-0.02
-14.89
-1.02
Diluted EPS
-0.21
--
-0.02
-14.89
-1.02
Basic Average Shares
136,932.0180
--
120,132.0130
66.3890
11,723.1820
Diluted Average Shares
136,932.0180
--
120,132.0130
66.3890
11,723.1820
Total Operating Income as Reported
-7,040
-7,040
-2,318
-877
-15,017
Rent Expense Supplemental
259
259
10
--
--
Total Expenses
7,040
7,040
2,319
878
16,017
Net Income from Continuing & Discontinued Operation
-28,778
-28,778
-2,041
-984
-11,940
Normalized Income
-9,508.6479
-9,508.6479
-1,596
-984
-15,831
Interest Income
57
57
3
0
24
Interest Expense
1,519
1,519
278
62
678
Net Interest Income
-2,716
-2,716
-286
-107
-723
EBIT
-27,509
-27,509
-2,771
-922
-15,076
EBITDA
-27,266
-27,266
-2,711
-909
-14,475
Reconciled Depreciation
243
243
60
13
601
Net Income from Continuing Operation Net Minority Interest
-28,778
-28,778
-2,041
-984
-15,831
Total Unusual Items Excluding Goodwill
-19,274
-19,274
-445
0
0
Total Unusual Items
-19,274
-19,274
-445
0
0
Normalized EBITDA
-7,992
-7,992
-2,266
-909
-14,475
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
-4.6479
-4.6479
0
0
0
12/31/2020 - 2/3/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYAD.BR Celyad Oncology SA
0.4500
-0.66%
OXUR.BR Oxurion NV
0.0700
+0.72%
BSFAF BSF Enterprise Plc
0.0584
0.00%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
328.SG MeiraGTx Holdings PLC
4.7600
-0.83%
6XC.F Soleno Therapeutics, Inc.
65.85
+2.81%
BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
25I.SG ImmuPharma PLC
0.0265
-10.17%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
AS00.F European Medical Solutions
5.24
0.00%